Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Jean Marie Bruey"'
Autor:
Wanlong Ma, Hagop Kantarjian, Xi Zhang, Xiuqiang Wang, Zhong Zhang, Chen-Hsiung Yeh, Susan O'Brien, Francis Giles, Jean Marie Bruey, Maher Albitar
Publikováno v:
PLoS ONE, Vol 5, Iss 8, p e12165 (2010)
BACKGROUND: The JAK2 V617F mutation in exon 14 is the most common mutation in chronic myeloproliferative neoplasms (MPNs); deletion of the entire exon 14 is rarely detected. In our previous study of >10,000 samples from patients with suspected MPNs t
Externí odkaz:
https://doaj.org/article/ab401484d9064add8d0cd69ffcb13c35
Autor:
Robert P. Frantz, Raymond L. Benza, Richard N. Channick, Kelly Chin, Luke S. Howard, Vallerie V. McLaughlin, Olivier Sitbon, Roham T. Zamanian, Anna R. Hemnes, Matt Cravets, Jean‐Marie Bruey, Robert Roscigno, David Mottola, Erin Elman, Lawrence S. Zisman, Hossein‐Ardeschir Ghofrani
Publikováno v:
Pulmonary Circulation, Vol 11, Iss 4, Pp 1-7 (2021)
Aberrant kinase signaling that involves platelet‐derived growth factor receptor (PDGFR) α/β, colony stimulating factor 1 receptor (CSF1R), and stem cell factor receptor (c‐KIT) pathways may be responsible for vascular remodeling in pulmonary ar
Externí odkaz:
https://doaj.org/article/e7c6ee3ea34a41f89721a2c6c04b54de
Autor:
Laura Carter, Andrea Wang-Gillam, Johanna Bendell, Wungki Park, Wells Messersmith, Drew Rasco, Lei Zhou, Jean-Marie Bruey, Beatrice Ferguson, Jakob Dupont, Marya Chaney, Johann De Bono, David Nickle, Anna Galkin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/4c3856eeaeb64d86ae0c6a78be6a0f14
Autor:
Mark H. Moss, Njira L. Lugogo, Mario Castro, Nicola A. Hanania, Andrea Ludwig-Sengpiel, Dinesh Saralaya, Rafal Dobek, Iñigo Ojanguren, Ivan Vyshnyvetskyy, Jean-Marie Bruey, Robin Osterhout, Cindy-ann Tompkins, Karen Dittrich, Kartik Raghupathi, Hector Ortega
Publikováno v:
Scientia
Asthma; Asthma worsening; Eosinophilic asthma Asma; Empitjorament de l'asma; Asma eosinofílica Asma; Empeoramiento del asma; Asma eosinofílica Background Prostaglandin D2 receptor 2 (DP2) antagonists inhibit prostaglandin D2-induced effects, includ
Autor:
Xiuting Liu, Graham D. Hogg, Chong Zuo, Nicholas C. Borcherding, John M. Baer, Varintra E. Lander, Liang-I Kang, Brett L. Knolhoff, Faiz Ahmad, Robin E. Osterhout, Anna V. Galkin, Jean-Marie Bruey, Laura L. Carter, Cedric Mpoy, Kiran R. Vij, Ryan C. Fields, Julie K. Schwarz, Haeseong Park, Vineet Gupta, David G. DeNardo
Publikováno v:
Cancer Cell.
Autor:
John C. Reed, Juan M. Zapata, Christina Kress, Benjamin Faustin, Jean-Marie Bruey, Nathalie Droin, Fréderic Luciano, Emilie Bard-Chapeau, Béatrice Bailly-Maitre
The liver has enormous regenerative capacity such that, after partial hepatectomy, hepatocytes rapidly replicate to restore liver mass, thus providing a context for studying in vivo mechanisms of cell growth regulation. Bax inhibitor-1 (BI-1) is an e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3120e43a504573f07d1bbef35939220f
https://doi.org/10.1158/0008-5472.c.6495128
https://doi.org/10.1158/0008-5472.c.6495128
Autor:
John C. Reed, Juan M. Zapata, Christina Kress, Benjamin Faustin, Jean-Marie Bruey, Nathalie Droin, Fréderic Luciano, Emilie Bard-Chapeau, Béatrice Bailly-Maitre
Supplementary Figures 1-5 from Mice Lacking bi-1 Gene Show Accelerated Liver Regeneration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66fd95cda40d7c5a0e0c9a8ca55c2c40
https://doi.org/10.1158/0008-5472.22366412.v1
https://doi.org/10.1158/0008-5472.22366412.v1
Autor:
John C. Reed, Juan M. Zapata, Christina Kress, Benjamin Faustin, Jean-Marie Bruey, Nathalie Droin, Fréderic Luciano, Emilie Bard-Chapeau, Béatrice Bailly-Maitre
Supplementary Figure Legends 1-5 from Mice Lacking bi-1 Gene Show Accelerated Liver Regeneration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0fec70091da6395f3f7db3751668fae
https://doi.org/10.1158/0008-5472.22366415.v1
https://doi.org/10.1158/0008-5472.22366415.v1
Autor:
Xiuting Liu, Graham D. Hogg, Chong Zuo, John M Baer, Varintra E. Lander, Liang Kang, Nicholas C. Borcherding, Brett L. Knolhoff, Robin E. Osterhout, Anna V. Galkin, Jean-Marie Bruey, Laura L. Carter, Cedric Mpoy, Julie K. Schwarz, Haeseong Park, Vineet Gupta, David G. DeNardo
Chronic activation of inflammatory pathways and suppressed interferon signaling are hallmarks of myeloid cells in immunosuppressive tumors that drive poor responsiveness to conventional and immune therapies. Previous studies have identified agonistic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d977918d9b74994bc7047294697c6beb
https://doi.org/10.1101/2022.03.22.485233
https://doi.org/10.1101/2022.03.22.485233
Autor:
Mark H, Moss, Njira L, Lugogo, Mario, Castro, Nicola A, Hanania, Andrea, Ludwig-Sengpiel, Dinesh, Saralaya, Rafal, Dobek, Iñigo, Ojanguren, Ivan, Vyshnyvetskyy, Jean-Marie, Bruey, Robin, Osterhout, Cindy-Ann, Tompkins, Karen, Dittrich, Kartik, Raghupathi, Hector, Ortega
Publikováno v:
Chest. 162(2)
Prostaglandin DWhat is the effect of the DPIn this phase IIb, randomized, double-blind, placebo-controlled, dose-ranging, parallel-group, multicenter study, GB001 or placebo was added to standard-of-care treatment in patients with moderate to severe